FIUME, LUIGI
FIUME, LUIGI
DIP. DI PATOLOGIA SPERIMENTALE
The inhibition of lactate dehydrogenase A hinders the transcription of histone 2B gene independently from the block of aerobic glycolysis
2017 Brighenti, Elisa; Carnicelli, Domenica; Brigotti, Maurizio; Fiume, Luigi
Lactate dehydrogenase inhibition: Exploring possible applications beyond cancer treatment
2016 Di Stefano, Giuseppina; Manerba, Marcella; Di Ianni, Lorenza; Fiume, Luigi
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes.
2015 M. Manerba; L. Di Ianni; L. Fiume; M. Roberti; M. Recanatini; G. Di Stefano
Albumin-drug conjugates in the treatment of hepatic disorders.
2014 Fiume L;Manerba M;Di Stefano G
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy
2014 Luigi FIUME; Marcella MANERBA; Marina VETTRAINO; Giuseppina DI STEFANO
Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells.
2013 Fiume L.; Vettraino M.; Carnicelli D.; Arfilli V.; Di Stefano G.; Brigotti M.
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase.
2012 Manerba M.; Vettraino M.; Fiume L.; Di Stefano G.; Sartini A.; Giacomini E.; Buonfiglio R.; Roberti M.; Recanatini M.
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
2012 Farabegoli F.; Vettraino M.; Manerba M.; Fiume L.; Roberti M.; Di Stefano G.
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells.
2011 Fiume L.; Manerba M.; Vettraino M.; Di Stefano G.
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors.
2011 Fiume L.; Vettraino M.; Manerba M.; Di Stefano G.
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.
2010 Fiume L; Manerba M; Vettraino M; Di Stefano G
Lactosaminated human albumin: a hepatotropic carrier of drugs.
2010 Fiume L.; Di Stefano G.
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy.
2009 Boga C.; Fiume L.; Baglioni M.; Bertucci C.; Farina C.; Kratz F.; Manerba M.; Naldi M.; Di Stefano G.
The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow.
2009 Fiume L.; Baglioni M.; Busi C.; Manerba M.; Di Stefano G.
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties.
2008 Baglioni M.; Fiume L.; Bolondi L.; Farina C.; Kratz F.; Di Stefano G.
Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats.
2008 Di Stefano G.; Fiume L.; Baglioni M.; Busi C.; Bolondi L.; Farina C.; Mori F.; Chieco P.; Pariali M.; Kratz F.; Molin L.; Salmaso S.; Caliceti P.
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug.
2008 Fiume L.; Baglioni M.; Bolondi L.; Farina C.; Di Stefano G.
Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging.
2008 Di Stefano G.; Fiume L.; Baglioni M.; Bolondi L.; Chieco P.; Kratz F.; Pariali M.; Rubini G.
Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin
2007 Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A.
A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade.
2006 Di Stefano G.; Fiume L.; Baglioni M.; Bolondi L.; Busi C.; Chieco P.; Kratz F.; Manaresi F.; Pariali M.